Lymphomas



Lymphomas





Systemic Lymphoma

Metastasis to CNS much more common with non-Hodgkin lymphoma (NHL) than with Hodgkin disease.

Nervous system sites involved in NHL: meninges (10%), epidural space (3% to 5%), brain (<1%, vs. primary CNS lymphoma, where >90% have brain parenchyma tumor).

Factors predisposing to CNS involvement: older age, bone marrow or retroperitoneal involvement, high serum lactic dehydrogenase (LDH).


Meningeal Lymphoma

4% to 11% of patients with NHL.



  • Clinical features: headache, nausea, vomiting, back pain, confusion, behavioral changes, cranial nerve palsies (commonly 3rd, 6th, 7th), limb weakness, sensory changes.


  • Diagnosis: MRI; CSF with lymphoma cells or elevated β2 microglobulin (tumor marker).



  • Treatment and prognosis: focal radiotherapy and intrathecal chemotherapy. Median survival 4 months; highly variable.


Epidural Spinal Cord Compression

5% of NHL patients. Usually direct extension from vertebral body metastases. Thoracic cord most common site; 5–10% have multifocal epidural tumor so entire spine should be imaged (noncontrast MRI sufficient).



  • Treatment: focal radiotherapy.


Primary CNS Lymphoma


Immunocompetent Patients


Epidemiology

3% of all intracranial neoplasms, 7% of all malignant lymphomas. Incidence rising in people >60, peak incidence age 40 to 60; M:F ratio 3:2.


Clinical Features

Behavioral changes and lateralizing symptoms (hemiparesis, aphasia, visual field deficits) common. Occasionally: seizures, ataxia, cranial nerve palsies. 20% have ocular disease (blurred vision, floaters, visual loss due to retinal detachment).


Diagnosis

Jul 27, 2016 | Posted by in NEUROLOGY | Comments Off on Lymphomas

Full access? Get Clinical Tree

Get Clinical Tree app for offline access